GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,983,000 | +115.3% | 146,600 | +1.0% | 0.01% | +133.3% |
Q2 2022 | $4,636,000 | -2.4% | 145,100 | +5.8% | 0.00% | 0.0% |
Q1 2022 | $4,749,000 | +31.6% | 137,100 | +11.2% | 0.00% | +50.0% |
Q4 2021 | $3,609,000 | +14.9% | 123,300 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $3,142,000 | -27.2% | 123,300 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $4,318,000 | -16.6% | 123,300 | -3.0% | 0.00% | 0.0% |
Q1 2021 | $5,179,000 | -4.3% | 127,100 | +1.8% | 0.00% | -25.0% |
Q4 2020 | $5,409,000 | -21.1% | 124,900 | +0.5% | 0.00% | -20.0% |
Q3 2020 | $6,854,000 | -11.1% | 124,300 | +1.7% | 0.01% | -28.6% |
Q2 2020 | $7,714,000 | +29.3% | 122,200 | +4.6% | 0.01% | +16.7% |
Q1 2020 | $5,967,000 | -34.6% | 116,800 | +1.8% | 0.01% | -33.3% |
Q4 2019 | $9,118,000 | +76.9% | 114,700 | +8.0% | 0.01% | +80.0% |
Q3 2019 | $5,153,000 | -6.5% | 106,200 | +1.3% | 0.01% | -16.7% |
Q2 2019 | $5,512,000 | +15.2% | 104,800 | +15.9% | 0.01% | +20.0% |
Q1 2019 | $4,785,000 | +33.4% | 90,400 | +3.4% | 0.01% | 0.0% |
Q4 2018 | $3,588,000 | +9.9% | 87,400 | +1.7% | 0.01% | +25.0% |
Q3 2018 | $3,264,000 | -8.6% | 85,900 | +8.7% | 0.00% | 0.0% |
Q2 2018 | $3,571,000 | -3.5% | 79,000 | +3.1% | 0.00% | -20.0% |
Q1 2018 | $3,700,000 | +27.6% | 76,600 | +3.9% | 0.01% | +66.7% |
Q4 2017 | $2,900,000 | +70.8% | 73,700 | +34.7% | 0.00% | +50.0% |
Q3 2017 | $1,698,000 | +18.5% | 54,700 | +4.4% | 0.00% | 0.0% |
Q2 2017 | $1,433,000 | -25.8% | 52,400 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,931,000 | +296.5% | 52,400 | +55.5% | 0.00% | +100.0% |
Q4 2016 | $487,000 | -24.8% | 33,700 | +19.9% | 0.00% | 0.0% |
Q3 2016 | $648,000 | +39.1% | 28,100 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $466,000 | +145.3% | 28,100 | +124.8% | 0.00% | – |
Q1 2016 | $190,000 | -38.7% | 12,500 | +30.2% | 0.00% | -100.0% |
Q4 2015 | $310,000 | – | 9,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
Grace Capital | 244,914 | $12,882,000 | 6.14% |
Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |